Robert Weinstein's Net Worth
$778 Thousand
Who is Robert Weinstein?
Robert Weinstein does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include XpresSpa Group, Inc., Synaptogenix, Inc., Neurotrope, Inc., Oblong, Inc., PharmaCyte Biotech, Inc., CDSS Wind Down Inc, Xcorporeal, Inc., XCORPOREAL, INC., and ABLE LABORATORIES INC.
SEC CIK
Robert Weinstein's CIK is 0001213709
Past Insider Trading and Trends
2015 was Robert Weinstein's most active year for acquiring shares with 7 total transactions. Robert Weinstein's most active month to acquire stocks was the month of October. 2004 was Robert Weinstein's most active year for disposing of shares, totalling 9 transactions. Robert Weinstein's most active month to dispose stocks was the month of November. 2004 saw Robert Weinstein paying a total of $540,800.00 for 38,500 shares, this is the most they've acquired in one year. In 2004 Robert Weinstein cashed out on 27,000 shares for a total of $296,759.58, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
XWELL, Inc. (XWEL) Snapshot price: $1.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.01% | 25K |
$0.25 | $6,175.00 | 156.49K |
May 30
| |||
Form 4
| +23.48% | 25K |
$0.25 | $6,250.00 | 131.49K |
May 26
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| -29.71% | -45.00K |
$1.06 | -$47,700.00 | 106.48K |
Scheduled
|
Apr 20
| ||
Form 4
| +18.91% | 31.25K |
—
|
—
| 196.49K |
Jan 26
| |||
Form 4
| -27.23% | -45.00K |
$1.56 | -$70,236.00 | 120.23K |
Scheduled
|
Jan 19
| ||
Form 4
| -27.60% | -63.00K |
$1.43 | -$90,209.70 | 165.24K |
Scheduled
|
Sep 20
| ||
Form 4
| +708.34% | 200K |
—
|
—
| 228.24K |
Jul 29
| |||
Form 4
|
∞
| 28.23K |
—
|
—
| 28.23K |
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Synaptogenix, Inc. (SNPX) Snapshot price: $3.6
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -44.85% | -27.00K |
$1.17 | -$31,641.30 | 33.2K |
Scheduled
|
Dec 16
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
| +30,303.03% | 60K |
—
|
—
| 60.2K |
Jul 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neurotrope, Inc. No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.95K |
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 4
| +193.33% | 83.33K |
$0.01 | $833.34 | 126.44K |
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 21
| |||
Form 4
| +34.48% | 43.1K |
—
|
—
| 168.1K |
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oblong, Inc. (OBLG) Snapshot price: $3.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PharmaCyte Biotech, Inc. (PMCB) Snapshot price: $1.62
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||